Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTCy and ATG for MSD and MUD Transplants
NCT06299462Phase 2Recruiting
- Sponsor
- Instituto Nacional de Câncer José Alencar Gomes da Silva
- Start
- Jun 2024
- Primary completion
- Jun 2031
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, antithymocyte globulin rabbit in graft-versus-host disease (GVHD), sponsored by Instituto Nacional de Câncer José Alencar Gomes da Silva. Started Jun 2024; status: recruiting.
02
Drugs
cyclophosphamideantithymocyte globulin rabbit
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT06299462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06299462.